Published in J Clin Invest on June 01, 2003
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol (2004) 3.76
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A (2004) 3.23
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A (2004) 2.38
The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol (2009) 2.23
Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol (2006) 1.91
Multiple organ infection and the pathogenesis of SARS. J Exp Med (2005) 1.58
Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med (2006) 1.40
Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates. J Virol (2005) 1.32
Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med (2006) 1.31
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.30
Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J Virol (2004) 1.23
A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies. J Gen Virol (2005) 1.17
Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis. J Clin Microbiol (2004) 1.17
Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus. J Clin Microbiol (2004) 1.13
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol (2005) 1.08
SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era. Philos Trans R Soc Lond B Biol Sci (2007) 1.03
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. J Virol (2008) 1.00
From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis (2013) 0.96
Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg Infect Dis (2004) 0.92
The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein. Virol J (2005) 0.89
False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clin Vaccine Immunol (2006) 0.88
Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis (2007) 0.85
The epitope study on the SARS-CoV nucleocapsid protein. Genomics Proteomics Bioinformatics (2003) 0.85
Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol (2005) 0.82
Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Genomics Proteomics Bioinformatics (2003) 0.81
Understanding Viral Transmission Behavior via Protein Intrinsic Disorder Prediction: Coronaviruses. J Pathog (2012) 0.79
Biochip sensors for the rapid and sensitive detection of viral disease. Genome Biol (2005) 0.79
Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. J Tradit Complement Med (2011) 0.77
Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals? Viruses (2015) 0.77
Channel inactivating mutations and their revertant mutants in the envelope protein of the infectious bronchitis virus. J Virol (2016) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 21.55
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Identification of severe acute respiratory syndrome in Canada. N Engl J Med (2003) 14.29
A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med (2003) 9.22
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol (2002) 3.69
Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report. BMJ (2003) 3.27
Faster... but fast enough? Responding to the epidemic of severe acute respiratory syndrome. N Engl J Med (2003) 1.88
Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol (2003) 1.79
WHO recommended measures for persons undertaking international travel from areas affected by severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec (2003) 1.72
The putative helicase of the coronavirus mouse hepatitis virus is processed from the replicase gene polyprotein and localizes in complexes that are active in viral RNA synthesis. J Virol (1999) 1.67
The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus. J Gen Virol (2001) 1.66
Two amino acid changes at the N-terminus of transmissible gastroenteritis coronavirus spike protein result in the loss of enteric tropism. Virology (1997) 1.43
Receptor-induced conformational changes of murine coronavirus spike protein. J Virol (2002) 1.39
Coronavirus genomic and subgenomic minus-strand RNAs copartition in membrane-protected replication complexes. J Virol (1997) 1.33
Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology (1997) 1.32
Conservation of substrate specificities among coronavirus main proteases. J Gen Virol (2002) 1.29
Quaternary structure of coronavirus spikes in complex with carcinoembryonic antigen-related cell adhesion molecule cellular receptors. J Biol Chem (2002) 1.23
The effects of coronavirus on human nasal ciliated respiratory epithelium. Eur Respir J (2001) 1.23
Isolation and propagation of a human enteric coronavirus. Science (1985) 1.20
Preliminary clinical description of severe acute respiratory syndrome. MMWR Morb Mortal Wkly Rep (2003) 1.19
Mucosal and systemic isotype-specific antibody responses and protection in conventional pigs exposed to virulent or attenuated porcine epidemic diarrhoea virus. Vet Immunol Immunopathol (2002) 1.00
The coronaviruses. Dev Biol Stand (1975) 0.86
Human enteric coronaviruses. Brief review. Arch Virol (1981) 0.85
Human enteric coronaviruses: further characterization and immunoblotting of viral proteins. J Infect Dis (1987) 0.81